RBC nanosponge (Cellics Therapeutics)

N/A

Report date: 2025/03/20 10:09:49

Base Information

Drug NameRBC nanosponge (Cellics Therapeutics)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAnemia, Hemolytic, AutoimmuneDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellics Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellics Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAnemia, Hemolytic, AutoimmuneDiabetic Foot
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A